{"id":4797,"date":"2025-10-03T11:47:31","date_gmt":"2025-10-03T16:47:31","guid":{"rendered":"https:\/\/wp.uthscsa.edu\/echo\/?page_id=4797"},"modified":"2026-03-27T11:02:51","modified_gmt":"2026-03-27T16:02:51","slug":"hepatitis-and-hiv-hepatitis-coinfection-echo","status":"publish","type":"page","link":"https:\/\/wp.uthscsa.edu\/echo\/hepatitis-and-hiv-hepatitis-coinfection-echo\/","title":{"rendered":"Hepatitis and HIV\/Hepatitis Coinfection ECHO"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><p>[vc_row][vc_column width=&#8221;2\/3&#8243;][vc_column_text css=&#8221;&#8221;][vc_row][vc_column width=&#8221;1\/1&#8243;][vc_column_text]<\/p>\n<h3>Hepatitis and HIV\/Hepatitis Coinfection ECHO<\/h3>\n<p>HIV, hepatitis B (HBV) and hepatitis C (HCV) share similar routes of transmission. Of those with HIV, approximately 6-14% also have HBV infection and 25% have HCV infection. The consequences of coinfection include quicker progression of liver disease, liver cirrhosis, end-stage liver disease and hepatocellular carcinoma. Join these sessions to learn evidence-based strategies for fighting this syndemic, connect with health professionals, and become part of the solution.<\/p>\n<p>Sessions are on third Wednesdays (12-1 pm CT) of each month<\/p>\n<p>Continuing Education credits for physicians, nurses, pharmacists, and pharmacist technicians are provided at no cost.<\/p>\n<p><a href=\"http:\/\/&quot;Navigating Dual Fronts: Diabetes Care Amid HCV and HBV Co-Infection&quot;&quot;Intersections of Chronic Illness: Managing Diabetes in the Landscape of Hepatitis B and C&quot;\">View Program Flyer \u00bb<\/a>[\/vc_column_text][\/vc_column][vc_column width=&#8221;1\/3&#8243;][vc_column_text css=&#8221;&#8221; el_class=&#8221;panel single-border colorized-border border-colorized-theme-accent single-border-top&#8221;]<\/p>\n<h2>Cases Needed!<\/h2>\n<p>ECHOs thrive on the contribution of all learners. If you want guidance or support, please consider presenting a case at our ECHO. Doing this is simple: just fill out a case presentation form online. Then join a session and take a few minutes to talk us through your case, your experience, and your questions for the learning network. We&#8217;ll facilitate discussion of the case and provide you with evidence-based, multidisciplinary mentorship on your next steps.<\/p>\n<p style=\"text-align: center;\"><a class=\"button \" href=\"https:\/\/redcap.uthscsa.edu\/REDCap\/surveys\/?s=RTKCDHFHWJ8CCTXW\" target=\"_blank\" rel=\"noopener\">Submit a case<\/a><\/p>\n<p>[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text]<!--more-->[\/vc_column_text][vc_separator color=&#8221;orange&#8221; border_width=&#8221;3&#8243;][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text css=&#8221;&#8221;]<\/p>\n<h1 style=\"text-align: center;\">Upcoming Session:<\/h1>\n<h2 style=\"text-align: center;\"><strong>Date:<\/strong> April 15, 2026 12-1pm CT<br \/>\n<strong>Topic:<\/strong> HIV\/HCV Coinfection &#8211; Treatment<\/h2>\n<h3 style=\"text-align: center;\"><a href=\"https:\/\/scaetc.unm.edu\/scaetc\/event\/?ER_ID=11616\">Register here<\/a><\/h3>\n<h2 style=\"text-align: center;\"><\/h2>\n<p>[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_separator color=&#8221;orange&#8221; border_width=&#8221;3&#8243; css=&#8221;&#8221;][\/vc_column][\/vc_row][vc_row][vc_column width=&#8221;1\/2&#8243;][vc_column_text css=&#8221;&#8221;]<\/p>\n<h3><strong>Session 25 &#8211; February 18, 2026 (12-1pm CT)<\/strong><\/h3>\n<ul>\n<li>Didactic Topic: <strong>Epidemiology of HIV\/HCV Coinfection in the United States<\/strong><\/li>\n<li>Presented by: Dr. Ruth Serrano, MD<\/li>\n<\/ul>\n<p>[\/vc_column_text][\/vc_column][vc_column width=&#8221;1\/2&#8243;][vc_single_image image=&#8221;5268&#8243; img_size=&#8221;full&#8221; alignment=&#8221;center&#8221; css=&#8221;&#8221;][\/vc_column][\/vc_row][vc_row][vc_column width=&#8221;1\/2&#8243;][vc_column_text css=&#8221;&#8221;]<\/p>\n<h3><strong>Session 25 &#8211; February 18, 2026 (12-1pm CT)<\/strong><\/h3>\n<ul>\n<li>Didactic Topic:<strong> From Start to SVR: Keeping HCV Antiviral Therapy on Track<\/strong><\/li>\n<li>Presented by: Dr. Divya Chandramohan, MD<\/li>\n<li><strong><a href=\"https:\/\/youtu.be\/p3cwGJTkeuo\">View Recordings \u00bb<\/a><\/strong><\/li>\n<\/ul>\n<p>[\/vc_column_text][\/vc_column][vc_column width=&#8221;1\/2&#8243;][vc_single_image image=&#8221;5195&#8243; img_size=&#8221;full&#8221; alignment=&#8221;center&#8221; css=&#8221;&#8221;][\/vc_column][\/vc_row][vc_row][vc_column width=&#8221;1\/2&#8243;][vc_column_text css=&#8221;&#8221;]<\/p>\n<h3><strong>Session 24 &#8211; January 21, 2026 (12-1pm CT)<\/strong><\/h3>\n<ul>\n<li>Didactic Topic:<strong> Viral Hepatitis A: <\/strong>Essential Clinical Insights for Providers<\/li>\n<li>Presented by: Dr. Victor Ankoma-sey, MD, FACP, FAASLD, AASLD<\/li>\n<\/ul>\n<p>[\/vc_column_text][\/vc_column][vc_column width=&#8221;1\/2&#8243;][vc_single_image image=&#8221;5134&#8243; img_size=&#8221;full&#8221; alignment=&#8221;center&#8221; css=&#8221;&#8221;][\/vc_column][\/vc_row][vc_row][vc_column width=&#8221;1\/2&#8243;][vc_column_text css=&#8221;&#8221;]<\/p>\n<h3><strong>Session 23 &#8211; December 17, 2025 (12-1pm CT)<\/strong><\/h3>\n<ul>\n<li>Didactic Topic:<strong> Communicating with patients about HIV and Hepatitis: <\/strong>Reducing Stigma and Delivering Diagnoses Effectively<\/li>\n<li>Presented by: Dr. Ruth Serrano Pinilla, MD<\/li>\n<li><strong><a href=\"https:\/\/youtu.be\/lJQoHSKfXfA\">View Recordings \u00bb<\/a><\/strong><\/li>\n<\/ul>\n<p>[\/vc_column_text][\/vc_column][vc_column width=&#8221;1\/2&#8243;][vc_single_image image=&#8221;5078&#8243; img_size=&#8221;full&#8221; alignment=&#8221;center&#8221; css=&#8221;&#8221;][\/vc_column][\/vc_row][vc_row][vc_column width=&#8221;1\/2&#8243;][vc_column_text css=&#8221;&#8221;]<\/p>\n<h3><strong>Session 22 &#8211; November 19, 2025 (12-1pm CT)<\/strong><\/h3>\n<ul>\n<li>Didactic Topic:<strong> Intersections of Chronic Illness:<\/strong> Managing Diabetes in the Landscape of Hepatitis B and C<\/li>\n<li>Presented by: Dewayne Davidson, PharmD<\/li>\n<li><strong><a href=\"https:\/\/youtu.be\/StmZNhtSYLY\">View Recordings \u00bb<\/a><\/strong><\/li>\n<\/ul>\n<p>[\/vc_column_text][\/vc_column][vc_column width=&#8221;1\/2&#8243;][vc_single_image image=&#8221;5068&#8243; img_size=&#8221;full&#8221; alignment=&#8221;center&#8221; css=&#8221;&#8221;][\/vc_column][\/vc_row][vc_row][vc_column width=&#8221;1\/2&#8243;][vc_column_text css=&#8221;&#8221;]<\/p>\n<h3><strong>Session 21 &#8211; October 15, 2025 (12-1pm CT)<\/strong><\/h3>\n<ul>\n<li>Didactic Topic: Transmission Risks Among Persons Who Use Drugs: HCV and HIV<\/li>\n<li>Presented by: Stevan Gonzalez, MD<\/li>\n<li><strong><a href=\"https:\/\/youtu.be\/705BzIL10KQ\">View Recordings \u00bb<\/a><\/strong><\/li>\n<\/ul>\n<p>[\/vc_column_text][\/vc_column][vc_column width=&#8221;1\/2&#8243;][vc_single_image image=&#8221;5015&#8243; img_size=&#8221;full&#8221; alignment=&#8221;center&#8221; css=&#8221;&#8221;][\/vc_column][\/vc_row][vc_row][vc_column width=&#8221;1\/2&#8243;][vc_column_text css=&#8221;&#8221;]<\/p>\n<h3><strong>Session 20 &#8211; September 17, 2025 (12-1pm CT)<\/strong><\/h3>\n<ul>\n<li>Didactic Topic: Introduction to Pre-Exposure Prophylaxis (PrEP)<\/li>\n<li>Presented by: Ruth Serrano Pinilla, MD<\/li>\n<li><strong><a href=\"https:\/\/youtu.be\/vcuf6rjORds\">View Recordings \u00bb<\/a><\/strong><\/li>\n<\/ul>\n<p>[\/vc_column_text][\/vc_column][vc_column width=&#8221;1\/2&#8243;][vc_single_image image=&#8221;4802&#8243; img_size=&#8221;full&#8221; alignment=&#8221;center&#8221; css=&#8221;&#8221;][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>[vc_row][vc_column width=&#8221;2\/3&#8243;][vc_column_text css=&#8221;&#8221;][vc_row][vc_column width=&#8221;1\/1&#8243;][vc_column_text] Hepatitis and HIV\/Hepatitis Coinfection ECHO HIV, hepatitis B (HBV) and hepatitis C (HCV) share similar routes of transmission. Of those with HIV, approximately 6-14% also have HBV infection and 25% have HCV infection. The consequences of coinfection include quicker progression of liver disease, liver cirrhosis, end-stage liver disease and hepatocellular carcinoma. [&hellip;]<\/p>\n","protected":false},"author":104,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-4797","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Hepatitis and HIV\/Hepatitis Coinfection ECHO - ECHO<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/wp.uthscsa.edu\/echo\/hepatitis-and-hiv-hepatitis-coinfection-echo\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Hepatitis and HIV\/Hepatitis Coinfection ECHO - ECHO\" \/>\n<meta property=\"og:description\" content=\"[vc_row][vc_column width=&#8221;2\/3&#8243;][vc_column_text css=&#8221;&#8221;][vc_row][vc_column width=&#8221;1\/1&#8243;][vc_column_text] Hepatitis and HIV\/Hepatitis Coinfection ECHO HIV, hepatitis B (HBV) and hepatitis C (HCV) share similar routes of transmission. Of those with HIV, approximately 6-14% also have HBV infection and 25% have HCV infection. The consequences of coinfection include quicker progression of liver disease, liver cirrhosis, end-stage liver disease and hepatocellular carcinoma. [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/wp.uthscsa.edu\/echo\/hepatitis-and-hiv-hepatitis-coinfection-echo\/\" \/>\n<meta property=\"og:site_name\" content=\"ECHO\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-27T16:02:51+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/wp.uthscsa.edu\/echo\/hepatitis-and-hiv-hepatitis-coinfection-echo\/\",\"url\":\"https:\/\/wp.uthscsa.edu\/echo\/hepatitis-and-hiv-hepatitis-coinfection-echo\/\",\"name\":\"Hepatitis and HIV\/Hepatitis Coinfection ECHO - ECHO\",\"isPartOf\":{\"@id\":\"https:\/\/wp.uthscsa.edu\/echo\/#website\"},\"datePublished\":\"2025-10-03T16:47:31+00:00\",\"dateModified\":\"2026-03-27T16:02:51+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/wp.uthscsa.edu\/echo\/hepatitis-and-hiv-hepatitis-coinfection-echo\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/wp.uthscsa.edu\/echo\/hepatitis-and-hiv-hepatitis-coinfection-echo\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/wp.uthscsa.edu\/echo\/hepatitis-and-hiv-hepatitis-coinfection-echo\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/wp.uthscsa.edu\/echo\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Hepatitis and HIV\/Hepatitis Coinfection ECHO\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/wp.uthscsa.edu\/echo\/#website\",\"url\":\"https:\/\/wp.uthscsa.edu\/echo\/\",\"name\":\"ECHO\",\"description\":\"UT Health San Antonio ECHO\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/wp.uthscsa.edu\/echo\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Hepatitis and HIV\/Hepatitis Coinfection ECHO - ECHO","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/wp.uthscsa.edu\/echo\/hepatitis-and-hiv-hepatitis-coinfection-echo\/","og_locale":"en_US","og_type":"article","og_title":"Hepatitis and HIV\/Hepatitis Coinfection ECHO - ECHO","og_description":"[vc_row][vc_column width=&#8221;2\/3&#8243;][vc_column_text css=&#8221;&#8221;][vc_row][vc_column width=&#8221;1\/1&#8243;][vc_column_text] Hepatitis and HIV\/Hepatitis Coinfection ECHO HIV, hepatitis B (HBV) and hepatitis C (HCV) share similar routes of transmission. Of those with HIV, approximately 6-14% also have HBV infection and 25% have HCV infection. The consequences of coinfection include quicker progression of liver disease, liver cirrhosis, end-stage liver disease and hepatocellular carcinoma. [&hellip;]","og_url":"https:\/\/wp.uthscsa.edu\/echo\/hepatitis-and-hiv-hepatitis-coinfection-echo\/","og_site_name":"ECHO","article_modified_time":"2026-03-27T16:02:51+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/wp.uthscsa.edu\/echo\/hepatitis-and-hiv-hepatitis-coinfection-echo\/","url":"https:\/\/wp.uthscsa.edu\/echo\/hepatitis-and-hiv-hepatitis-coinfection-echo\/","name":"Hepatitis and HIV\/Hepatitis Coinfection ECHO - ECHO","isPartOf":{"@id":"https:\/\/wp.uthscsa.edu\/echo\/#website"},"datePublished":"2025-10-03T16:47:31+00:00","dateModified":"2026-03-27T16:02:51+00:00","breadcrumb":{"@id":"https:\/\/wp.uthscsa.edu\/echo\/hepatitis-and-hiv-hepatitis-coinfection-echo\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/wp.uthscsa.edu\/echo\/hepatitis-and-hiv-hepatitis-coinfection-echo\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/wp.uthscsa.edu\/echo\/hepatitis-and-hiv-hepatitis-coinfection-echo\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/wp.uthscsa.edu\/echo\/"},{"@type":"ListItem","position":2,"name":"Hepatitis and HIV\/Hepatitis Coinfection ECHO"}]},{"@type":"WebSite","@id":"https:\/\/wp.uthscsa.edu\/echo\/#website","url":"https:\/\/wp.uthscsa.edu\/echo\/","name":"ECHO","description":"UT Health San Antonio ECHO","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/wp.uthscsa.edu\/echo\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/wp.uthscsa.edu\/echo\/wp-json\/wp\/v2\/pages\/4797","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/wp.uthscsa.edu\/echo\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/wp.uthscsa.edu\/echo\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/wp.uthscsa.edu\/echo\/wp-json\/wp\/v2\/users\/104"}],"replies":[{"embeddable":true,"href":"https:\/\/wp.uthscsa.edu\/echo\/wp-json\/wp\/v2\/comments?post=4797"}],"version-history":[{"count":5,"href":"https:\/\/wp.uthscsa.edu\/echo\/wp-json\/wp\/v2\/pages\/4797\/revisions"}],"predecessor-version":[{"id":5313,"href":"https:\/\/wp.uthscsa.edu\/echo\/wp-json\/wp\/v2\/pages\/4797\/revisions\/5313"}],"wp:attachment":[{"href":"https:\/\/wp.uthscsa.edu\/echo\/wp-json\/wp\/v2\/media?parent=4797"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}